<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>CADASIL Type 1 - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
            --banner-bg: #fef3c7;
            --banner-border: #f59e0b;
            --banner-text: #92400e;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .notice-banner {
            background: var(--banner-bg);
            color: var(--banner-text);
            border-bottom: 1px solid var(--banner-border);
            padding: 12px 16px;
            text-align: center;
            font-size: 0.95rem;
            cursor: pointer;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "â†³ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="notice-banner" role="button" tabindex="0">This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.</div>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>CADASIL Type 1</span>
        </nav>

        <header class="page-header">
            <h1>CADASIL Type 1</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Mendelian</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0007432" target="_blank">
                        MONDO:0007432
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Hereditary Stroke Disorder</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Small Vessel Disease</span>
                
            </div>
            
            <p style="margin-top: 16px; font-size: 1rem; line-height: 1.6; opacity: 0.95; position: relative;">
                Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a hereditary small vessel disease caused by mutations in the NOTCH3 gene. It is the most common monogenic cause of stroke and vascular dementia in adults. The disease is characterized by recurrent ischemic strokes, progressive cognitive decline, migraine with aura, and psychiatric disturbances. Pathologically, it involves progressive degeneration of vascular smooth muscle cells in small arteries, abnormal accumulation of the NOTCH3 extracellular domain (ECD) as granular osmiophilic material (GOM), and co-deposition of extracellular matrix proteins, leading to thickening of vessel walls and luminal narrowing.
            </p>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <a class="stat-link" href="#inheritance">
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Inheritance</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Pathophysiology</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">9</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#genetic">
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Genes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
            
        </div>

        <!-- Classifications -->
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        
        <div class="card" id="inheritance">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #92400e;">ðŸ‘ª</div>
                <h2 class="card-title">Inheritance</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box inheritance-box">
                <div class="item-name">
                    Autosomal Dominant
                    
                </div>
                
                <div class="item-desc">CADASIL follows autosomal dominant inheritance with high penetrance. De novo mutations are rare but reported.</div>
                
                
    
    
    
    
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3389/fneur.2025.1662012" target="_blank">DOI:10.3389/fneur.2025.1662012</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"CADASIL is an autosomal dominant disorder characterized by midlife-onset cerebrovascular disease and dementia."</div>
                
                
                <div class="evidence-explanation">This review confirms the autosomal dominant inheritance pattern of CADASIL.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Subtypes -->
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">âš™</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">NOTCH3 Mutation and ECD Aggregation</div>
                
                <div class="item-desc">Mutations in NOTCH3, primarily missense mutations affecting cysteine residues in the extracellular EGF-like repeat domains, lead to abnormal NOTCH3 extracellular domain (ECD) multimerization and accumulation in small vessel walls. Wild-type and mutant NOTCH3 ECD co-aggregate, and this co-aggregation is a major driver of arterial pathology and vascular smooth muscle cell loss.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        vascular associated smooth muscle cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000359" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        pericyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000669" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Notch signaling pathway
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0007219" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        brain
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0000955" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38386425" target="_blank">PMID:38386425</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"wild-type Notch3ECD coaggregated with mutant Notch3ECD and that elimination of 1 copy of wild-type Notch3 in TgNotch3R169C was sufficient to attenuate Notch3ECD accumulation and arterial pathology. These findings suggest that Notch3ECD accumulation, involving mutant and wild-type NOTCH3, is a..."</div>
                
                
                <div class="evidence-explanation">This study demonstrates that wild-type and mutant NOTCH3 ECD co-aggregate, and that reducing wild-type NOTCH3 attenuates both ECD accumulation and arterial pathology in a mouse model, supporting aggregation-driven toxicity as a major disease mechanism.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3390/biom14010127" target="_blank">DOI:10.3390/biom14010127</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"CADASIL caused by NOTCH3 is adult-onset and considered to be caused by accumulation of the mutant NOTCH3 extracellular domain (N3ECD) and, possibly, by an impairment in Notch signaling."</div>
                
                
                <div class="evidence-explanation">This review confirms the dual-mechanism framework for CADASIL: N3ECD accumulation combined with possible Notch signaling impairment.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Granular Osmiophilic Material (GOM) Accumulation</div>
                
                <div class="item-desc">Characteristic pathological deposits of granular osmiophilic material accumulate in the basement membrane of small arteries. GOM contains NOTCH3 extracellular domain fragments along with co-deposited extracellular matrix proteins including TIMP3 and vitronectin. GOM deposition is pathognomonic for CADASIL and correlates with vascular smooth muscle cell degeneration.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        vascular associated smooth muscle cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000359" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        extracellular matrix organization
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0030198" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30855338" target="_blank">PMID:30855338</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Granular osmiophilic material deposits around blood vessels are also a unique CADASIL feature and appear to have a role in sequestering proteins that are essential for blood vessel homeostasis."</div>
                
                
                <div class="evidence-explanation">This review confirms GOM deposits as a unique pathological feature of CADASIL that sequesters proteins important for vascular homeostasis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3389/fnmol.2024.1391040" target="_blank">DOI:10.3389/fnmol.2024.1391040</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"The NOTCH3 R75Q mouse model showed pathological characteristics of CADASIL, with age-dependent NOTCH3ECD, granular osmiophilic material, and degenerated smooth muscle cells detected in the brain."</div>
                
                
                <div class="evidence-explanation">The NOTCH3 R75Q knock-in mouse model recapitulates GOM deposition and smooth muscle cell degeneration in an age-dependent manner, confirming the link between GOM accumulation and VSMC loss.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Small Vessel Arteriopathy and Hypoperfusion</div>
                
                <div class="item-desc">Progressive thickening of arterial walls with loss of vascular smooth muscle cells leads to luminal narrowing, reduced cerebral blood flow, and chronic hypoperfusion of subcortical white matter. This results in white matter injury, lacunar infarcts, and progressive neurodegeneration.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        vascular associated smooth muscle cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000359" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        endothelial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000115" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        vascular associated smooth muscle cell apoptotic process
                        
                        <a href="http://purl.obolibrary.org/obo/GO_1905288" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        cerebral hemisphere white matter
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002437" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38386425" target="_blank">PMID:38386425</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"Loss of arterial smooth muscle cells (SMCs) and abnormal accumulation of the extracellular domain of the NOTCH3 receptor (Notch3ECD) are the 2 core features of CADASIL, a common cerebral small vessel disease caused by highly stereotyped dominant mutations in NOTCH3."</div>
                
                
                <div class="evidence-explanation">This paper identifies arterial smooth muscle cell loss and NOTCH3 ECD accumulation as the two core pathological features of CADASIL.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Immune Activation and ECM Remodeling</div>
                
                <div class="item-desc">Proteomic profiling in CADASIL patients reveals an immune- and matrisome-oriented plasma signature with elevated RSPO1, FGF19, MMP-10 and reduced PPY, alongside enrichment of complement/inflammatory pathways, leukocyte adhesion, and ECM organization, supporting roles for vascular remodeling and immune activation in disease progression.</div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        proteolysis
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006508" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        extracellular matrix organization
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0030198" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3390/jcm13113138" target="_blank">DOI:10.3390/jcm13113138</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Significant differences in protein expression were observed between CADASIL patients and controls. RSPO1 and FGF-19 exhibited elevated levels (p &lt; 0.05), while PPY showed downregulation (p &lt; 0.05) in CADASIL patients, suggesting their involvement in disease pathogenesis."</div>
                
                
                <div class="evidence-explanation">Proteomic analysis identifies differentially expressed proteins in CADASIL plasma with enrichment of complement/inflammatory and ECM organization pathways.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">â—</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">9</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Cardiovascular<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Nervous System<span class="pill-count">(8)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Cardiovascular
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Recurrent Ischemic Stroke
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0032325" target="_blank">
                                Lacunar stroke
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0032325)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3389/fneur.2025.1573052" target="_blank">DOI:10.3389/fneur.2025.1573052</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The clinical manifestations of CADASIL include migraines, recurrent ischemic stroke, progressive cognitive deterioration, and psychiatric symptoms."</div>
                
                
                <div class="evidence-explanation">This review confirms recurrent ischemic stroke as a core clinical manifestation of CADASIL.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30855338" target="_blank">PMID:30855338</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"CADASIL is a genotypically and phenotypically diverse condition involving multiple molecular systems affecting small blood vessels."</div>
                
                
                <div class="evidence-explanation">This review confirms CADASIL as a small vessel disease affecting cerebral vasculature, consistent with lacunar stroke pathology.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Nervous System
                    <span class="cat-count">8</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Migraine with Aura
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002077" target="_blank">
                                Migraine with aura
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002077)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3389/fneur.2025.1573052" target="_blank">DOI:10.3389/fneur.2025.1573052</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The clinical manifestations of CADASIL include migraines, recurrent ischemic stroke, progressive cognitive deterioration, and psychiatric symptoms."</div>
                
                
                <div class="evidence-explanation">This review lists migraines as a core clinical manifestation of CADASIL.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Cognitive Impairment
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0100543" target="_blank">
                                Cognitive impairment
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0100543)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3389/fneur.2025.1573052" target="_blank">DOI:10.3389/fneur.2025.1573052</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The clinical manifestations of CADASIL include migraines, recurrent ischemic stroke, progressive cognitive deterioration, and psychiatric symptoms."</div>
                
                
                <div class="evidence-explanation">This review confirms progressive cognitive deterioration as a core CADASIL phenotype.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3389/fneur.2025.1662012" target="_blank">DOI:10.3389/fneur.2025.1662012</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"CADASIL is an autosomal dominant disorder characterized by midlife-onset cerebrovascular disease and dementia."</div>
                
                
                <div class="evidence-explanation">This review describes dementia as a defining feature of CADASIL.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Mood Disturbances
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000716" target="_blank">
                                Depression
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000716)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3389/fneur.2025.1573052" target="_blank">DOI:10.3389/fneur.2025.1573052</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The clinical manifestations of CADASIL include migraines, recurrent ischemic stroke, progressive cognitive deterioration, and psychiatric symptoms."</div>
                
                
                <div class="evidence-explanation">Psychiatric symptoms, including mood disturbances, are listed as a core clinical manifestation of CADASIL.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        White Matter Hyperintensities
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0030890" target="_blank">
                                Hyperintensity of cerebral white matter on MRI
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0030890)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3389/fneur.2025.1573052" target="_blank">DOI:10.3389/fneur.2025.1573052</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The most prevalent and earliest imaging alterations in CADASIL are white matter hyperintensities in the periventricular white matter, temporal pole, external capsule, frontoparietal white matter, and other areas on magnetic resonance imaging."</div>
                
                
                <div class="evidence-explanation">This review confirms white matter hyperintensities in characteristic locations as the most prevalent and earliest imaging finding in CADASIL.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30855338" target="_blank">PMID:30855338</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Cerebral white matter changes observed by MRI are a key CADASIL characteristic in young adult patients often before severe symptoms and trigger NOTCH3 genetic testing."</div>
                
                
                <div class="evidence-explanation">This review confirms cerebral white matter MRI changes as a key early CADASIL characteristic that often prompts genetic testing.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Leukoencephalopathy
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002352" target="_blank">
                                Leukoencephalopathy
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002352)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3389/fneur.2025.1662012" target="_blank">DOI:10.3389/fneur.2025.1662012</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"CADASIL is an autosomal dominant disorder characterized by midlife-onset cerebrovascular disease and dementia. It is caused by mutations in the NOTCH3 gene, which affects the amount of cysteine in the extracellular domain (ECD) of the receptor, leading to protein misfolding and receptor aggregation."</div>
                
                
                <div class="evidence-explanation">Leukoencephalopathy is part of the disease name and a defining feature, supported by the progressive white matter injury from NOTCH3-driven vasculopathy.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Dementia
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000726" target="_blank">
                                Dementia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000726)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3389/fneur.2025.1662012" target="_blank">DOI:10.3389/fneur.2025.1662012</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"CADASIL is an autosomal dominant disorder characterized by midlife-onset cerebrovascular disease and dementia."</div>
                
                
                <div class="evidence-explanation">Dementia is identified as a defining characteristic of CADASIL.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Apathy
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000741" target="_blank">
                                Apathy
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000741)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3389/fneur.2025.1573052" target="_blank">DOI:10.3389/fneur.2025.1573052</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The clinical manifestations of CADASIL include migraines, recurrent ischemic stroke, progressive cognitive deterioration, and psychiatric symptoms."</div>
                
                
                <div class="evidence-explanation">Apathy is a common psychiatric symptom in CADASIL, grouped under the broader psychiatric manifestations.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Gait Disturbance
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001288" target="_blank">
                                Gait disturbance
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001288)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3389/fneur.2025.1573052" target="_blank">DOI:10.3389/fneur.2025.1573052</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The clinical manifestations of CADASIL include migraines, recurrent ischemic stroke, progressive cognitive deterioration, and psychiatric symptoms."</div>
                
                
                <div class="evidence-explanation">Gait disturbance results from cumulative subcortical ischemic injury in CADASIL, consistent with the progressive motor disability described in this review.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card" id="genetic">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">ðŸ§¬</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    NOTCH3
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Causative)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3389/fneur.2025.1662012" target="_blank">DOI:10.3389/fneur.2025.1662012</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"It is caused by mutations in the NOTCH3 gene, which affects the amount of cysteine in the extracellular domain (ECD) of the receptor, leading to protein misfolding and receptor aggregation. Emerging evidence indicates that beyond classical missense mutations, other variants including..."</div>
                
                
                <div class="evidence-explanation">This review confirms NOTCH3 mutations as causative and describes the expanding spectrum of pathogenic variants beyond classical cysteine-altering mutations.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30855338" target="_blank">PMID:30855338</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"NOTCH3 mutation locations are highly variable, correlate to disease severity and consistently affect the cysteine balance within extracellular Notch3."</div>
                
                
                <div class="evidence-explanation">This review confirms that NOTCH3 mutations consistently affect cysteine balance and that mutation location correlates with disease severity.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3389/fnmol.2024.1391040" target="_blank">DOI:10.3389/fnmol.2024.1391040</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"We demonstrate that NOTCH3ECD induced by NOTCH3 R75Q mutation has toxic effects on cells and reveal the deposition characteristics of NOTCH3ECD in the brain. This provides a feasible model and lays the foundation for further studies on the pathogenesis and therapeutic strategies of NOTCH3..."</div>
                
                
                <div class="evidence-explanation">This study provides in vitro and in vivo evidence that the cysteine-sparing NOTCH3 R75Q mutation is pathogenic, expanding the spectrum of causative NOTCH3 variants.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">ðŸ’Š</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Antiplatelet Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Secondary stroke prevention with antiplatelet agents, though evidence specific to CADASIL is limited.</div>
                
                
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Migraine Prophylaxis
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Management of migraine with aura, avoiding vasoconstrictors like triptans due to theoretical stroke risk.</div>
                
                
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Supportive Care
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000950" target="_blank">
                            MAXO:0000950
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Management of vascular risk factors, cognitive rehabilitation, and treatment of psychiatric symptoms.</div>
                
                
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Genetic Counseling
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000079" target="_blank">
                            MAXO:0000079
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Genetic counseling is recommended for affected individuals and at-risk family members given the autosomal dominant inheritance pattern and high penetrance.</div>
                
                
                
                
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        

        <!-- Biochemical Markers -->
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: CADASIL Type 1
description: &gt;-
  Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and
  Leukoencephalopathy (CADASIL) is a hereditary small vessel disease caused by
  mutations in the NOTCH3 gene. It is the most common monogenic cause of stroke
  and vascular dementia in adults. The disease is characterized by recurrent
  ischemic strokes, progressive cognitive decline, migraine with aura, and
  psychiatric disturbances. Pathologically, it involves progressive degeneration
  of vascular smooth muscle cells in small arteries, abnormal accumulation of the
  NOTCH3 extracellular domain (ECD) as granular osmiophilic material (GOM), and
  co-deposition of extracellular matrix proteins, leading to thickening of
  vessel walls and luminal narrowing.
category: Mendelian
disease_term:
  preferred_term: CADASIL
  term:
    id: MONDO:0007432
    label: cerebral arteriopathy with subcortical infarcts and leukoencephalopathy
parents:
  - Hereditary Stroke Disorder
  - Small Vessel Disease
pathophysiology:
  - name: NOTCH3 Mutation and ECD Aggregation
    description: &gt;-
      Mutations in NOTCH3, primarily missense mutations affecting cysteine
      residues in the extracellular EGF-like repeat domains, lead to abnormal
      NOTCH3 extracellular domain (ECD) multimerization and accumulation in
      small vessel walls. Wild-type and mutant NOTCH3 ECD co-aggregate, and
      this co-aggregation is a major driver of arterial pathology and vascular
      smooth muscle cell loss.
    gene:
      preferred_term: NOTCH3
      description: &gt;-
        Receptor whose extracellular domain aggregates into granular osmiophilic
        material (GOM) deposits, driving vascular smooth muscle cell loss and
        arteriopathy.
      term:
        id: hgnc:7883
        label: NOTCH3
    cell_types:
      - preferred_term: vascular associated smooth muscle cell
        term:
          id: CL:0000359
          label: vascular associated smooth muscle cell
      - preferred_term: pericyte
        term:
          id: CL:0000669
          label: pericyte
    biological_processes:
      - preferred_term: Notch signaling pathway
        term:
          id: GO:0007219
          label: Notch signaling pathway
    locations:
      - preferred_term: brain
        term:
          id: UBERON:0000955
          label: brain
    evidence:
      - reference: PMID:38386425
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: &gt;-
          wild-type Notch3ECD coaggregated with mutant Notch3ECD and that
          elimination of 1 copy of wild-type Notch3 in TgNotch3R169C was
          sufficient to attenuate Notch3ECD accumulation and arterial pathology.
          These findings suggest that Notch3ECD accumulation, involving mutant
          and wild-type NOTCH3, is a major driver of arterial SMC loss in
          CADASIL, paving the way for NOTCH3-lowering therapeutic strategies.
        explanation: &gt;-
          This study demonstrates that wild-type and mutant NOTCH3 ECD
          co-aggregate, and that reducing wild-type NOTCH3 attenuates both
          ECD accumulation and arterial pathology in a mouse model, supporting
          aggregation-driven toxicity as a major disease mechanism.
      - reference: DOI:10.3390/biom14010127
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          CADASIL caused by NOTCH3 is adult-onset and considered to be caused
          by accumulation of the mutant NOTCH3 extracellular domain (N3ECD)
          and, possibly, by an impairment in Notch signaling.
        explanation: &gt;-
          This review confirms the dual-mechanism framework for CADASIL:
          N3ECD accumulation combined with possible Notch signaling impairment.
  - name: Granular Osmiophilic Material (GOM) Accumulation
    description: &gt;-
      Characteristic pathological deposits of granular osmiophilic material
      accumulate in the basement membrane of small arteries. GOM contains
      NOTCH3 extracellular domain fragments along with co-deposited
      extracellular matrix proteins including TIMP3 and vitronectin. GOM
      deposition is pathognomonic for CADASIL and correlates with vascular
      smooth muscle cell degeneration.
    cell_types:
      - preferred_term: vascular associated smooth muscle cell
        term:
          id: CL:0000359
          label: vascular associated smooth muscle cell
    biological_processes:
      - preferred_term: extracellular matrix organization
        term:
          id: GO:0030198
          label: extracellular matrix organization
    evidence:
      - reference: PMID:30855338
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          Granular osmiophilic material deposits around blood vessels are also
          a unique CADASIL feature and appear to have a role in sequestering
          proteins that are essential for blood vessel homeostasis.
        explanation: &gt;-
          This review confirms GOM deposits as a unique pathological feature of
          CADASIL that sequesters proteins important for vascular homeostasis.
      - reference: DOI:10.3389/fnmol.2024.1391040
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: &gt;-
          The NOTCH3 R75Q mouse model showed pathological characteristics of
          CADASIL, with age-dependent NOTCH3ECD, granular osmiophilic material,
          and degenerated smooth muscle cells detected in the brain.
        explanation: &gt;-
          The NOTCH3 R75Q knock-in mouse model recapitulates GOM deposition
          and smooth muscle cell degeneration in an age-dependent manner,
          confirming the link between GOM accumulation and VSMC loss.
  - name: Small Vessel Arteriopathy and Hypoperfusion
    description: &gt;-
      Progressive thickening of arterial walls with loss of vascular smooth
      muscle cells leads to luminal narrowing, reduced cerebral blood flow,
      and chronic hypoperfusion of subcortical white matter. This results in
      white matter injury, lacunar infarcts, and progressive neurodegeneration.
    cell_types:
      - preferred_term: vascular associated smooth muscle cell
        term:
          id: CL:0000359
          label: vascular associated smooth muscle cell
      - preferred_term: endothelial cell
        term:
          id: CL:0000115
          label: endothelial cell
    biological_processes:
      - preferred_term: vascular associated smooth muscle cell apoptotic process
        term:
          id: GO:1905288
          label: vascular associated smooth muscle cell apoptotic process
    locations:
      - preferred_term: cerebral hemisphere white matter
        term:
          id: UBERON:0002437
          label: cerebral hemisphere white matter
    evidence:
      - reference: PMID:38386425
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: &gt;-
          Loss of arterial smooth muscle cells (SMCs) and abnormal accumulation
          of the extracellular domain of the NOTCH3 receptor (Notch3ECD) are
          the 2 core features of CADASIL, a common cerebral small vessel
          disease caused by highly stereotyped dominant mutations in NOTCH3.
        explanation: &gt;-
          This paper identifies arterial smooth muscle cell loss and NOTCH3 ECD
          accumulation as the two core pathological features of CADASIL.
  - name: Immune Activation and ECM Remodeling
    description: &gt;-
      Proteomic profiling in CADASIL patients reveals an immune- and
      matrisome-oriented plasma signature with elevated RSPO1, FGF19, MMP-10
      and reduced PPY, alongside enrichment of complement/inflammatory pathways,
      leukocyte adhesion, and ECM organization, supporting roles for vascular
      remodeling and immune activation in disease progression.
    biological_processes:
      - preferred_term: proteolysis
        term:
          id: GO:0006508
          label: proteolysis
      - preferred_term: extracellular matrix organization
        term:
          id: GO:0030198
          label: extracellular matrix organization
    evidence:
      - reference: DOI:10.3390/jcm13113138
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          Significant differences in protein expression were observed between
          CADASIL patients and controls. RSPO1 and FGF-19 exhibited elevated
          levels (p &lt; 0.05), while PPY showed downregulation (p &lt; 0.05) in
          CADASIL patients, suggesting their involvement in disease pathogenesis.
        explanation: &gt;-
          Proteomic analysis identifies differentially expressed proteins in
          CADASIL plasma with enrichment of complement/inflammatory and ECM
          organization pathways.
phenotypes:
  - name: Recurrent Ischemic Stroke
    category: Neurological
    frequency: VERY_FREQUENT
    description: &gt;-
      Subcortical lacunar infarcts are the hallmark feature, typically
      beginning in the 4th-5th decade. Most patients experience multiple
      strokes leading to cumulative disability.
    phenotype_term:
      preferred_term: Lacunar stroke
      term:
        id: HP:0032325
        label: Lacunar stroke
    evidence:
      - reference: DOI:10.3389/fneur.2025.1573052
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          The clinical manifestations of CADASIL include migraines, recurrent
          ischemic stroke, progressive cognitive deterioration, and psychiatric
          symptoms.
        explanation: &gt;-
          This review confirms recurrent ischemic stroke as a core clinical
          manifestation of CADASIL.
      - reference: PMID:30855338
        supports: NO_EVIDENCE
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          CADASIL is a genotypically and phenotypically diverse condition
          involving multiple molecular systems affecting small blood vessels.
        explanation: &gt;-
          This review confirms CADASIL as a small vessel disease affecting
          cerebral vasculature, consistent with lacunar stroke pathology.
  - name: Migraine with Aura
    category: Neurological
    frequency: FREQUENT
    description: &gt;-
      Migraine with aura, often with prolonged or atypical aura, is frequently
      the earliest manifestation, appearing in the 2nd-3rd decade.
    phenotype_term:
      preferred_term: Migraine with aura
      term:
        id: HP:0002077
        label: Migraine with aura
    evidence:
      - reference: DOI:10.3389/fneur.2025.1573052
        supports: PARTIAL
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          The clinical manifestations of CADASIL include migraines, recurrent
          ischemic stroke, progressive cognitive deterioration, and psychiatric
          symptoms.
        explanation: &gt;-
          This review lists migraines as a core clinical manifestation of
          CADASIL.
  - name: Cognitive Impairment
    category: Neurological
    frequency: VERY_FREQUENT
    description: &gt;-
      Progressive cognitive decline affecting executive function, processing
      speed, and memory. Vascular dementia develops in most patients by age 65.
    phenotype_term:
      preferred_term: Cognitive impairment
      term:
        id: HP:0100543
        label: Cognitive impairment
    evidence:
      - reference: DOI:10.3389/fneur.2025.1573052
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          The clinical manifestations of CADASIL include migraines, recurrent
          ischemic stroke, progressive cognitive deterioration, and psychiatric
          symptoms.
        explanation: &gt;-
          This review confirms progressive cognitive deterioration as a core
          CADASIL phenotype.
      - reference: DOI:10.3389/fneur.2025.1662012
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          CADASIL is an autosomal dominant disorder characterized by
          midlife-onset cerebrovascular disease and dementia.
        explanation: &gt;-
          This review describes dementia as a defining feature of CADASIL.
  - name: Mood Disturbances
    category: Psychiatric
    frequency: FREQUENT
    description: &gt;-
      Depression and apathy are common, often preceding or accompanying
      cognitive decline. Some patients develop more severe psychiatric symptoms.
    phenotype_term:
      preferred_term: Depression
      term:
        id: HP:0000716
        label: Depression
    evidence:
      - reference: DOI:10.3389/fneur.2025.1573052
        supports: PARTIAL
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          The clinical manifestations of CADASIL include migraines, recurrent
          ischemic stroke, progressive cognitive deterioration, and psychiatric
          symptoms.
        explanation: &gt;-
          Psychiatric symptoms, including mood disturbances, are listed as a
          core clinical manifestation of CADASIL.
  - name: White Matter Hyperintensities
    category: Neuroimaging
    frequency: VERY_FREQUENT
    description: &gt;-
      Extensive white matter hyperintensities on T2/FLAIR MRI, characteristically
      involving the anterior temporal lobes and external capsules - a pattern
      relatively specific for CADASIL.
    phenotype_term:
      preferred_term: Hyperintensity of cerebral white matter on MRI
      term:
        id: HP:0030890
        label: Hyperintensity of cerebral white matter on MRI
    evidence:
      - reference: DOI:10.3389/fneur.2025.1573052
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          The most prevalent and earliest imaging alterations in CADASIL are
          white matter hyperintensities in the periventricular white matter,
          temporal pole, external capsule, frontoparietal white matter, and
          other areas on magnetic resonance imaging.
        explanation: &gt;-
          This review confirms white matter hyperintensities in characteristic
          locations as the most prevalent and earliest imaging finding in
          CADASIL.
      - reference: PMID:30855338
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          Cerebral white matter changes observed by MRI are a key CADASIL
          characteristic in young adult patients often before severe symptoms
          and trigger NOTCH3 genetic testing.
        explanation: &gt;-
          This review confirms cerebral white matter MRI changes as a key early
          CADASIL characteristic that often prompts genetic testing.
  - name: Leukoencephalopathy
    category: Neurological
    frequency: VERY_FREQUENT
    description: &gt;-
      Progressive damage to the white matter of the cerebrum resulting from
      chronic small vessel disease and hypoperfusion. This is the defining
      neuropathological feature reflected in the disease name.
    phenotype_term:
      preferred_term: Leukoencephalopathy
      term:
        id: HP:0002352
        label: Leukoencephalopathy
    evidence:
      - reference: DOI:10.3389/fneur.2025.1662012
        supports: NO_EVIDENCE
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          CADASIL is an autosomal dominant disorder characterized by
          midlife-onset cerebrovascular disease and dementia. It is caused by
          mutations in the NOTCH3 gene, which affects the amount of cysteine
          in the extracellular domain (ECD) of the receptor, leading to protein
          misfolding and receptor aggregation.
        explanation: &gt;-
          Leukoencephalopathy is part of the disease name and a defining
          feature, supported by the progressive white matter injury from
          NOTCH3-driven vasculopathy.
  - name: Dementia
    category: Neurological
    frequency: FREQUENT
    description: &gt;-
      Progressive vascular dementia developing from cumulative ischemic
      injury and white matter disease. Most patients develop dementia by
      their 6th-7th decade.
    phenotype_term:
      preferred_term: Dementia
      term:
        id: HP:0000726
        label: Dementia
    evidence:
      - reference: DOI:10.3389/fneur.2025.1662012
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          CADASIL is an autosomal dominant disorder characterized by
          midlife-onset cerebrovascular disease and dementia.
        explanation: &gt;-
          Dementia is identified as a defining characteristic of CADASIL.
  - name: Apathy
    category: Psychiatric
    frequency: FREQUENT
    description: &gt;-
      Reduced motivation and initiative, often accompanying cognitive decline
      and contributing to functional disability.
    phenotype_term:
      preferred_term: Apathy
      term:
        id: HP:0000741
        label: Apathy
    evidence:
      - reference: DOI:10.3389/fneur.2025.1573052
        supports: PARTIAL
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          The clinical manifestations of CADASIL include migraines, recurrent
          ischemic stroke, progressive cognitive deterioration, and psychiatric
          symptoms.
        explanation: &gt;-
          Apathy is a common psychiatric symptom in CADASIL, grouped under
          the broader psychiatric manifestations.
  - name: Gait Disturbance
    category: Neurological
    frequency: FREQUENT
    description: &gt;-
      Progressive gait difficulties resulting from subcortical ischemic
      injury and white matter disease.
    phenotype_term:
      preferred_term: Gait disturbance
      term:
        id: HP:0001288
        label: Gait disturbance
    evidence:
      - reference: DOI:10.3389/fneur.2025.1573052
        supports: NO_EVIDENCE
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          The clinical manifestations of CADASIL include migraines, recurrent
          ischemic stroke, progressive cognitive deterioration, and psychiatric
          symptoms.
        explanation: &gt;-
          Gait disturbance results from cumulative subcortical ischemic injury
          in CADASIL, consistent with the progressive motor disability
          described in this review.
genetic:
  - name: NOTCH3
    association: Causative
    gene_term:
      preferred_term: NOTCH3
      term:
        id: hgnc:7883
        label: NOTCH3
    notes: &gt;-
      Autosomal dominant mutations in NOTCH3 cause CADASIL. Over 95% are
      missense mutations affecting cysteine residues in the 34 EGF-like
      repeat domains, leading to an odd number of cysteines and abnormal
      protein folding. Cysteine-sparing variants can also cause CADASIL-like
      pathology.
    evidence:
      - reference: DOI:10.3389/fneur.2025.1662012
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          It is caused by mutations in the NOTCH3 gene, which affects the
          amount of cysteine in the extracellular domain (ECD) of the receptor,
          leading to protein misfolding and receptor aggregation. Emerging
          evidence indicates that beyond classical missense mutations, other
          variants including cysteine-sparing missense mutations, homozygous
          mutations, small deletions, duplications, splice site mutations,
          a deletion/insertion and loss-of-function mutations may lead to
          distinct phenotypes with variable severity and disease penetrance.
        explanation: &gt;-
          This review confirms NOTCH3 mutations as causative and describes
          the expanding spectrum of pathogenic variants beyond classical
          cysteine-altering mutations.
      - reference: PMID:30855338
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          NOTCH3 mutation locations are highly variable, correlate to disease
          severity and consistently affect the cysteine balance within
          extracellular Notch3.
        explanation: &gt;-
          This review confirms that NOTCH3 mutations consistently affect
          cysteine balance and that mutation location correlates with disease
          severity.
      - reference: DOI:10.3389/fnmol.2024.1391040
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: &gt;-
          We demonstrate that NOTCH3ECD induced by NOTCH3 R75Q mutation has
          toxic effects on cells and reveal the deposition characteristics of
          NOTCH3ECD in the brain. This provides a feasible model and lays the
          foundation for further studies on the pathogenesis and therapeutic
          strategies of NOTCH3 cysteine-sparing mutations.
        explanation: &gt;-
          This study provides in vitro and in vivo evidence that the
          cysteine-sparing NOTCH3 R75Q mutation is pathogenic, expanding
          the spectrum of causative NOTCH3 variants.
inheritance:
  - name: Autosomal Dominant
    description: &gt;-
      CADASIL follows autosomal dominant inheritance with high penetrance.
      De novo mutations are rare but reported.
    evidence:
      - reference: DOI:10.3389/fneur.2025.1662012
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: &gt;-
          CADASIL is an autosomal dominant disorder characterized by
          midlife-onset cerebrovascular disease and dementia.
        explanation: &gt;-
          This review confirms the autosomal dominant inheritance pattern
          of CADASIL.
treatments:
  - name: Antiplatelet Therapy
    description: &gt;-
      Secondary stroke prevention with antiplatelet agents, though evidence
      specific to CADASIL is limited.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
  - name: Migraine Prophylaxis
    description: &gt;-
      Management of migraine with aura, avoiding vasoconstrictors like
      triptans due to theoretical stroke risk.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
  - name: Supportive Care
    description: &gt;-
      Management of vascular risk factors, cognitive rehabilitation, and
      treatment of psychiatric symptoms.
    treatment_term:
      preferred_term: supportive care
      term:
        id: MAXO:0000950
        label: supportive care
  - name: Genetic Counseling
    description: &gt;-
      Genetic counseling is recommended for affected individuals and
      at-risk family members given the autosomal dominant inheritance
      pattern and high penetrance.
    treatment_term:
      preferred_term: genetic counseling
      term:
        id: MAXO:0000079
        label: genetic counseling
datasets:
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/CADASIL_Type_1.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
    <script>
        (function() {
            const banner = document.querySelector('.notice-banner');
            if (!banner) return;
            const dismiss = () => banner.remove();
            banner.addEventListener('click', dismiss);
            banner.addEventListener('keydown', (event) => {
                if (event.key === 'Enter' || event.key === ' ') {
                    event.preventDefault();
                    dismiss();
                }
            });
        })();
    </script>
</body>
</html>